PIK3CA and colorectal carcinoma: Preclinical data showed the importance of a PTEN/PI3K/AKT pathway determining the CRC cell line sensitivity to cetuximab, and in particular, PTEN loss presents a resistance to cetuximab-induced apoptosis [23].